ABSTRACT Small extracellular vesicles (sEVs) are promising vehicles for targeted therapeutic delivery, but strategies for their surface functionalization remain limited. Here, we present a reliable and simple genetic approach that enables customized modification of sEV surfaces and supports enhanced sEV uptake by recipient cells. This strategy is based on the fusion of targeting moieties to the C‐terminal fragment of syndecan‐1 (SDC1‐CTF), a peptide naturally enriched in sEVs. Combining various analytical approaches including single‐vesicle analysis, we establish that this strategy enables decoration of up to 20% of secreted sEVs with Nanobodies (Nbs). In quantitative bioluminescence assays, using concentrated conditioned media, we demonstrate that sEV‐coating with anti‐EGFR Nb supports enhanced sEV uptake by EGFR‐expressing cells. This new strategy thus offers a robust and modular solution for endowing sEV surfaces with defined targeting properties to support further sEV‐based therapeutic applications.
Hyka et al. (Fri,) studied this question.